Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingyi Chen

Showing results (91-100 of 216) with videos related to

Pageof 22
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2022
p73α1, a p73 C-terminal isoform, regulates tumor suppression and the inflammatory response via Notch1Kyra Nicole Laubach, Wensheng Yan, Xiangmudong Kong, et al.
Seminars in Diagnostic Pathology|March 8, 2023
Deep learning in digital pathology for personalized treatment plans of cancer patientsZhuoyu Wen, Shidan Wang, Donghan M Yang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2014
Increased antitumor effects using IL-2 with anti-TGF-β reveals competition between mouse NK and CD8 T cellsMaite Alvarez, Myriam N Bouchlaka, Gail D Sckisel, et al.
Cancers|July 2, 2021
Small Proline-Rich Protein 2A and 2D Are Regulated by the RBM38-p73 Axis and Associated with p73-Dependent Suppression of Chronic InflammationXiangmudong Kong, Dan Wang, Wenqiang Sun, et al.
Cardiovascular & Hematological Disorders Drug Targets|June 28, 2019
CD123: A Novel Biomarker for Diagnosis and Treatment of LeukemiaMingyue Shi, Ruijun J Su, Kamal-Preet Parmar, et al.
Cell Death & Disease|January 11, 2023
TP73 Isoform-specific disruption reveals a critical role of TAp73beta in growth suppression and inflammatory responseJin Zhang, Wenqiang Sun, Wensheng Yan, et al.
International Journal of Laboratory Hematology|January 4, 2024
Clinicopathologic features of relapsed CD19(-) B-ALL in CD19-targeted immunotherapy: Biological insights into relapse and LILRB1 as a novel B-cell marker for CD19(-) B lymphoblastsDong Chen, Franklin Fuda, Flavia Rosado, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|September 23, 2014
[Clinicopathological and CT features of mucinous cystic neoplasms of the pancreas]Li Yan, Yongliang Chen, Wenzhi Zhang, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|December 15, 2015
[Treatment and prognosis of solid pseudopapillary neoplasms with metastases or recurrence]Mingyue Xu, Xianjie Shi, Tao Wan, et al.
Scientific Reports|October 28, 2021
Nanofiber template-induced preparation of ZnO nanocrystal and its application in photocatalysisMingyi Chen, Peng Liu, Ji-Huan He, et al.
Pageof 22

Showing results (91-100 of 216) with videos related to

Sort By:
Pageof 22
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2022
p73α1, a p73 C-terminal isoform, regulates tumor suppression and the inflammatory response via Notch1Kyra Nicole Laubach, Wensheng Yan, Xiangmudong Kong, et al.
Seminars in Diagnostic Pathology|March 8, 2023
Deep learning in digital pathology for personalized treatment plans of cancer patientsZhuoyu Wen, Shidan Wang, Donghan M Yang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2014
Increased antitumor effects using IL-2 with anti-TGF-β reveals competition between mouse NK and CD8 T cellsMaite Alvarez, Myriam N Bouchlaka, Gail D Sckisel, et al.
Cancers|July 2, 2021
Small Proline-Rich Protein 2A and 2D Are Regulated by the RBM38-p73 Axis and Associated with p73-Dependent Suppression of Chronic InflammationXiangmudong Kong, Dan Wang, Wenqiang Sun, et al.
Cardiovascular & Hematological Disorders Drug Targets|June 28, 2019
CD123: A Novel Biomarker for Diagnosis and Treatment of LeukemiaMingyue Shi, Ruijun J Su, Kamal-Preet Parmar, et al.
Cell Death & Disease|January 11, 2023
TP73 Isoform-specific disruption reveals a critical role of TAp73beta in growth suppression and inflammatory responseJin Zhang, Wenqiang Sun, Wensheng Yan, et al.
International Journal of Laboratory Hematology|January 4, 2024
Clinicopathologic features of relapsed CD19(-) B-ALL in CD19-targeted immunotherapy: Biological insights into relapse and LILRB1 as a novel B-cell marker for CD19(-) B lymphoblastsDong Chen, Franklin Fuda, Flavia Rosado, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|September 23, 2014
[Clinicopathological and CT features of mucinous cystic neoplasms of the pancreas]Li Yan, Yongliang Chen, Wenzhi Zhang, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|December 15, 2015
[Treatment and prognosis of solid pseudopapillary neoplasms with metastases or recurrence]Mingyue Xu, Xianjie Shi, Tao Wan, et al.
Scientific Reports|October 28, 2021
Nanofiber template-induced preparation of ZnO nanocrystal and its application in photocatalysisMingyi Chen, Peng Liu, Ji-Huan He, et al.
Pageof 22